ANI Pharmaceuticals, Inc.

US$67.41As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ANIPHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 1.22%
Div yield —
ROE 20.45%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.47
PE TTM 13.47
TSR TTM (25.60%)
Mkt cap US$1.428B
ROIC 13.58%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$86
28.31%
(45.26%)
Buy 12|6|1|9|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.72
0.76
0.84
0.89
19.33%
20.95%
35.52%
35.11%
Revenue$M
93.82
98.99
104.7
103.7
4.17%
10.81%
12.61%
14.57%
Peers (US$1.428B)
Cap (US$)
PE
1.461B
39.91x
1.429B
7.130x
Capital
TTM
5Y
10Y
Leveragex
3.463
0.481
0.522
EBIT/Intx
0.145
0.328
0.258
Own earn%
125.09
14.51
(8.05)
Sh yield%
19.70
38.82
34.32
Owners
Insiders/Inst%
12.05
68.39
Short interest%
4.70
SBC / revenue%
0.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
26–32
$1 testx
—
Incr. ROIC%
7